ログイン
ランキング
お知らせ
ログイン
文献詳細
増大特集 治せる認知症
文献概要
高齢者では薬物による認知機能障害が生じやすい。せん妄や認知症は薬物の毒性により生じることが知られており，特に抗コリン作用の強い薬物は急性，あるいは慢性の認知機能障害の原因となる。向精神薬，抗うつ薬，抗てんかん薬もせん妄や認知症をきたしやすい。高齢者に対しては副作用の少ない薬物を選択して慎重に処方量の調整を行う，常に副作用の発現に注意を払うなど，薬物による認知機能障害の予防と早期発見が重要である。
参考文献
1)Inouye SK, Westendorp RGJ, Saczynski JS: Delirium in elderly people. Lancet 383: 911-922, 2014
2)Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 275: 852-857, 1996
3)Catic AG: Identification and management of in-hospital drug-induced delirium in older patients. Drugs Aging 28: 737-748, 2011
4)せん妄. 日本精神神経学会（監）: DSM-5精神疾患の診断統計マニュアル. 医学書院, 東京, 2014, pp588-594
5)Inouye SK: Delirium in older persons. N Engl J Med 354: 1157-1165, 2006
6)Davis DH, Muniz Terrera G, Keage H, Rahkonen T, Oinas M, et al: Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain 135: 2809-2816, 2012
7)Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, et al: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340: 669-676, 1999
8)Larson EB, Kukull WA, Buchner D, Reifler BV: Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107: 169-173, 1987
9)Moore AR, O'Keeffe ST: Drug-induced cognitive impairment in the elderly. Drugs Aging 15: 15-28, 1999
10)日本老年医学会（編）: 高齢者の安全な薬物療法ガイドライン2015. メジカルビュー社, 東京, 2015
11)Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, et al: Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175: 401-407, 2015
12)Blazer DG 2nd, Federspiel CF, Ray WA, Schaffner W: The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 38: 31-35, 1983
13)Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, et al: Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 169: 1317-1324, 2009
14)Barbee JG: Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J Clin Psychiatry 54: 86-97, 1993
15)Barker MJ, Greenwood KM, Jackson M, Crowe SF: Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18: 37-48, 2004
16)Barker MJ, Greenwood KM, Jackson M, Crowe SF: Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 19: 437-454, 2004
17)Eitan N, Levin Y, Ben-Artzi E, Lery A, Neumann M: Effects of antipsychotic drugs on memory functions of schizophrenic patients. Acta Psychiatr Scand 85: 74-76, 1992
18)抗コリン薬. 日本神経学会（編）: パーキンソン病治療ガイドライン2011. 医学書院, 東京, 2011, pp38-39
19)Branconnier RJ, Cole JO: Effects of acute administration of trazodone and amitryptiline on cognition, cardiovascular function and salivation in the normal geriatric subject. J Clin Psychopharmacol 1: 825-828, 1986
20)Rudorfer MV, Manji HK, Potter WZ: Comparative tolerability profiles of the newer versus older antidepressants. Drug Saf 10: 18-46, 1994
21)Trimble MR: Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 28 (suppl 3): S37-S45, 1987
22)Schentag JJ, Cerra FB, Calleri G, DeGlopper E, Rose JQ, et al: Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177-181, 1979
23)Fireman Z, Kopelman Y, Sternberg A: Central nervous system side effects after proton pump inhibitor treatment. J Clin Gastroenterol 25: 718, 1997
24)Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, et al: Muscaric receptors: their distribution and function in body systems, and the implication for treating overactive bladder. Br J Pharmacol 148: 565-575, 2006
25)Paquette A, Gou P, Tannenbaum C: Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? J Am Geriatr Soc 59: 1332-1339, 2011
26)Wagg A, Dale M, Tretter R, Stow B, Compion G: Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR Study. Eur Urol 64: 74-81, 2013
27)The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in reaction to dosage. Clin Pharmacol Ther 13: 694-698, 1972
28)Sapolsky RM: Glucocorticoids, stress and exacerbation of excitotoxic neuron death. Semin Neurosci 6: 323-331, 1994
29)Steele TE, Morton WA Jr: Salicylate-induced delirium. Psychosomatics 27: 455-456, 1986
30)Schwartz JI, Moura RJ: Severe depersonalization and anxiety associated with indomethacin. South Med J 76: 679-680, 1983
31)Thornton T: Delirium associated with sulindac. JAMA 243: 1630-1631, 1980
32)Goodwin JS, Regan M: Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum 25: 1013-1015, 1982
33)Eisendrath SJ, Sweeny MA: Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations. Am J Psychiatry 144: 506-507, 1987
34)Dimsdale JE, Newton RP, Joist T: Neuropsychological side effects of beta-blockers. Arch Intern Med 149: 514-525, 1989
35)Patten SB, Williams JV, Love EJ: Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 41: 469-476, 1996
36)Ahmad S: Losartan and reversible psychosis. Cardiology 87: 569-570, 1996
37)Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, et al: Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63: 1324-1325, 2004
38)Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, et al: Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340: b5465, 2010
39)Lewis DO: Serendipitous relief with disopyramide of phobia for flying. Am J Psychiatry 144: 159-163, 1987
掲載誌情報
